| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.032 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |